Cargando…

Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition

Respiratory syncytial virus (RSV) causes severe pulmonary disease in infants, young children, and the elderly. Formalin inactivated RSV (FI-RSV) vaccine trials failed due to vaccine enhanced respiratory disease, but the underlying immune mechanisms remain not fully understood. In this study, we have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, Eun-Ju, Lee, Youri, Lee, Young-Tae, Hwang, Hye Suk, Park, Yoonsuh, Kim, Ki-Hye, Kang, Sang-Moo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779866/ https://www.ncbi.nlm.nih.gov/pubmed/33425436 http://dx.doi.org/10.4110/in.2020.20.e51

Ejemplares similares

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge
por: Park, Soojin, et al.
Publicado: (2018)

Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
por: Kim, Ki-Hye, et al.
Publicado: (2015)

Ginseng Protects Against Respiratory Syncytial Virus by Modulating Multiple Immune Cells and Inhibiting Viral Replication
por: Lee, Jong Seok, et al.
Publicado: (2015)

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
por: Killikelly, April M., et al.
Publicado: (2016)

Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform
por: Kwon, Young-Man, et al.
Publicado: (2019)

Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages
por: Lee, Young-Tae, et al.
Publicado: (2015)

Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
por: Derscheid, Rachel J., et al.
Publicado: (2013)

Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection
por: Hwang, Hye Suk, et al.
Publicado: (2021)

Antiviral activity of ginseng extract against respiratory syncytial virus infection
por: LEE, JONG SEOK, et al.
Publicado: (2014)

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient
por: Besteman, Sjanna B, et al.
Publicado: (2022)

Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus
por: Jung, Yu-Jin, et al.
Publicado: (2020)

Respiratory syncytial virus is an “opportunistic” killer
por: Caballero, Mauricio T., et al.
Publicado: (2018)

Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination
por: Ko, Eun-Ju, et al.
Publicado: (2017)

Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
por: Kim, Ki-Hye, et al.
Publicado: (2018)

Development and Function of CD94-Deficient Natural Killer Cells
por: Orr, Mark T., et al.
Publicado: (2010)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Transient Depletion of CD169(+) Cells Contributes to Impaired Early Protection and Effector CD8(+) T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection
por: Oh, Dong Sun, et al.
Publicado: (2017)

BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection
por: Kim, Ki-Hye, et al.
Publicado: (2021)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Antiviral activity of carnosic acid against respiratory syncytial virus
por: Shin, Han-Bo, et al.
Publicado: (2013)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
por: Muralidharan, Abenaya, et al.
Publicado: (2018)

Aerosol Survival, Disinfection and Formalin Inactivation of Nipah Virus
por: Smither, Sophie J., et al.
Publicado: (2022)

Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus
por: Lin, Syh-Jae, et al.
Publicado: (2016)

Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection
por: Jung, Hi Eun, et al.
Publicado: (2020)

TLR-4 and CD14 Polymorphisms in Respiratory Syncytial Virus Associated Disease
por: Puthothu, Beena, et al.
Publicado: (2006)

Cytokines and CD8 T cell immunity during respiratory syncytial virus infection
por: Schmidt, Megan E., et al.
Publicado: (2020)

Unusual CD4(+)CD28(−) T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders
por: Lee, Ga Hye, et al.
Publicado: (2016)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

Inactivation of respiratory syncytial virus by zinc finger reactive compounds
por: Boukhvalova, Marina S, et al.
Publicado: (2010)

Influenza, Respiratory Syncytial Virus and COVID-19: Three Respiratory Killers at Risk to Patients
por: Mitchell, Edith Peterson
Publicado: (2022)

CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1
por: Du, Xiangnan, et al.
Publicado: (2018)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
por: Kennedy, Mary K., et al.
Publicado: (2000)

Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3(+)CD5(dim)CD21(−) Cytotoxic Large Granular Lymphocytes
por: Lee, Soo-Hyeon, et al.
Publicado: (2018)

Comparison of xTAG Respiratory Virus Panel and Verigene Respiratory Virus Plus for Detecting Influenza Virus and Respiratory Syncytial Virus
por: Hwang, Sang Mee, et al.
Publicado: (2014)

Comparison of FcRγ-Deficient and CD57+ Natural Killer Cells Between Cord Blood and Adult Blood in the Cytomegalovirus-Endemic Korean Population
por: Baek, Hee Jo, et al.
Publicado: (2015)

Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection
por: Schmidt, Megan E., et al.
Publicado: (2018)

Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue
por: Hatano, Ryo, et al.
Publicado: (2014)

High Efficiency of Antiviral CD4(+) Killer T Cells
por: Hildemann, Steven K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_go7mn8utj8q1ujj2h25qhgdd4j